http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110358737-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
filingDate 2019-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110358737-B
titleOfInvention Method for preparing chimeric antigen receptor T lymphocyte by using exosome
abstract The invention provides a method for preparing chimeric antigen receptor T lymphocytes by using exosomes, which comprises the following steps: (1) obtaining T lymphocytes of a subject; (2) culturing the T lymphocyte, and extracting exosome; then continuing culturing the T lymphocyte to obtain a T lymphocyte culture A; (3) transfecting the exosome with a plasmid expressing an antigen chimeric receptor to obtain an exosome containing a CAR plasmid; (4) mixing and culturing the exosome containing the CAR plasmid in (3) and the T lymphocyte culture A in (2) to obtain the antigen chimeric receptor T lymphocyte. The invention also provides an exosome, an antigen chimeric receptor T lymphocyte prepared according to the method and application of the antigen chimeric receptor T lymphocyte in preparing a medicament for treating cancer.
priorityDate 2019-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9ERA7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID10232
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID212256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428545465
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56047
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID60333
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ61468
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID212256
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ13421
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73755215

Total number of triples: 34.